Market revenue in 2023 | USD 943.6 million |
Market revenue in 2030 | USD 1,319.0 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Pcr-based diagnostics |
Fastest growing segment | NGS DNA Diagnosis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 49.88% in 2023. Horizon Databook has segmented the Canada dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The market in Canada is expected to grow at a lucrative rate over the forecast period. It follows the U.S. in adopting diagnostic tests, as FDA-approved tests are permitted in the country. The presence of microbiology facilities in the country is expected to drive the DNA diagnostics market growth.
For instance, the National Microbiology Laboratory (NML) in Canada is renowned for its exceptional level of scientific research worldwide. Organizations collaborate with international and Canadian public health partners to prevent the spread of transmissible diseases.
Laboratories’ primary functions include research, lab-based surveillance, and specialized services to identify diseases that other labs may not be able to detect or diagnose, among others. A group of local community representatives make up the Community Liaison Committee (CLC), which is a subsidiary body of the Canadian Science Centre for Human and Animal Health (CSCHAH).
Horizon Databook provides a detailed overview of country-level data and insights on the Canada dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account